BE879263A - Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose - Google Patents
Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce composeInfo
- Publication number
- BE879263A BE879263A BE0/197526A BE197526A BE879263A BE 879263 A BE879263 A BE 879263A BE 0/197526 A BE0/197526 A BE 0/197526A BE 197526 A BE197526 A BE 197526A BE 879263 A BE879263 A BE 879263A
- Authority
- BE
- Belgium
- Prior art keywords
- same
- methyl
- methods
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7839978 | 1978-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE879263A true BE879263A (fr) | 1980-04-08 |
Family
ID=10500226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/197526A BE879263A (fr) | 1978-10-10 | 1979-10-08 | Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose |
Country Status (10)
| Country | Link |
|---|---|
| JP (2) | JPS5562065A (nl) |
| BE (1) | BE879263A (nl) |
| CA (1) | CA1117117A (nl) |
| CH (1) | CH642353A5 (nl) |
| DE (1) | DE2940833A1 (nl) |
| FR (1) | FR2438654A1 (nl) |
| GB (1) | GB2036722B (nl) |
| IT (1) | IT1125469B (nl) |
| NL (1) | NL7907482A (nl) |
| SE (2) | SE446265B (nl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7910521L (sv) * | 1979-12-20 | 1981-06-21 | Haessle Ab | Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma |
| JPS57175164A (en) * | 1981-04-18 | 1982-10-28 | Banyu Pharmaceut Co Ltd | 1,4-dihydropyridine derivative and its preparation |
| DE3269219D1 (en) * | 1981-11-17 | 1986-03-27 | Fisons Plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
| ZA83959B (en) * | 1982-03-10 | 1984-09-26 | Sandoz Ltd | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
| CH655110A5 (de) * | 1982-09-03 | 1986-03-27 | Otsuka Pharma Co Ltd | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. |
| DE3312216A1 (de) * | 1983-04-05 | 1984-10-11 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern |
| JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンａ物質含有易溶性固形製剤 |
| GB8412208D0 (en) * | 1984-05-12 | 1984-06-20 | Pfizer Ltd | Quinolone inotropic agents |
| GB8431119D0 (en) * | 1984-12-10 | 1985-01-16 | Fujisawa Pharmaceutical Co | Anti-arteriosclerotic composition |
| GB8602518D0 (en) * | 1986-02-01 | 1986-03-05 | Wyeth John & Brother Ltd | 1 4-dihydropyridines |
| JPS63115890A (ja) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | ２位置換１，４−ジヒドロピリジン誘導体 |
| ES2043719T3 (es) * | 1987-06-12 | 1994-01-01 | American Cyanamid Co | Administracion de farmacos por via percutanea. |
| US5114946A (en) * | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
| US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
| CA1318596C (en) * | 1987-12-29 | 1993-06-01 | Takaharu Ono | Venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound |
| EP0322747B1 (en) * | 1987-12-29 | 1994-03-02 | Fujisawa Pharmaceutical Co., Ltd. | A brain neuron protecting agent containing a dihydropyridine compound |
| JP2007230869A (ja) * | 2004-04-05 | 2007-09-13 | Takeda Chem Ind Ltd | アルドステロン受容体拮抗剤 |
| CN103951608B (zh) * | 2009-08-04 | 2016-04-27 | 喜德生（苏州）医药科技有限公司 | 尼伐地平晶型及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
| DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1979
- 1979-09-21 CA CA000336130A patent/CA1117117A/en not_active Expired
- 1979-10-08 BE BE0/197526A patent/BE879263A/fr not_active IP Right Cessation
- 1979-10-08 FR FR7925007A patent/FR2438654A1/fr active Granted
- 1979-10-09 NL NL7907482A patent/NL7907482A/nl active Search and Examination
- 1979-10-09 IT IT26362/79A patent/IT1125469B/it active Protection Beyond IP Right Term
- 1979-10-09 DE DE19792940833 patent/DE2940833A1/de active Granted
- 1979-10-09 JP JP13053079A patent/JPS5562065A/ja active Granted
- 1979-10-09 SE SE7908367A patent/SE446265B/sv not_active IP Right Cessation
- 1979-10-09 GB GB7935022A patent/GB2036722B/en not_active Expired
- 1979-10-10 CH CH912879A patent/CH642353A5/de not_active IP Right Cessation
-
1984
- 1984-02-09 SE SE8400689A patent/SE446096B/sv not_active IP Right Cessation
-
1985
- 1985-09-26 JP JP60214152A patent/JPS61118366A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB2036722A (en) | 1980-07-02 |
| DE2940833C2 (nl) | 1989-01-26 |
| JPS6143343B2 (nl) | 1986-09-26 |
| IT7926362A0 (it) | 1979-10-09 |
| CH642353A5 (de) | 1984-04-13 |
| SE446265B (sv) | 1986-08-25 |
| SE446096B (sv) | 1986-08-11 |
| SE8400689D0 (sv) | 1984-02-09 |
| DE2940833A1 (de) | 1980-04-30 |
| JPS5562065A (en) | 1980-05-10 |
| SE7908367L (sv) | 1980-04-11 |
| CA1117117A (en) | 1982-01-26 |
| GB2036722B (en) | 1982-12-01 |
| SE8400689L (sv) | 1984-02-09 |
| NL7907482A (nl) | 1980-04-14 |
| JPS61118366A (ja) | 1986-06-05 |
| IT1125469B (it) | 1986-05-14 |
| JPS6125711B2 (nl) | 1986-06-17 |
| FR2438654A1 (fr) | 1980-05-09 |
| FR2438654B1 (nl) | 1983-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE879263A (fr) | Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose | |
| PT64770B (fr) | Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-difenilicos. | |
| BE877596A (fr) | Nouvelles oxybenzylidene bornanones, procede pour leur preparation et compositions cosmetiques les contenant | |
| BE873526A (fr) | Produit d'addition aux materiaux de construction | |
| NL930110I1 (nl) | Carbazolyl-(4)-oxypropanolamine-derivaten werkwijze ter bereiding daarvan en geneesmiddelen die dezeverbindingen bevatten | |
| PH16326A (en) | New chemical compounds,pharmaceutical compositions containing the same and method of use | |
| FR2530143B1 (fr) | Composition medicinale contenant du pirprofen | |
| IT8019049A0 (it) | Composti 2 penem, metodo per laloro preparazione e composizioni farmaceutiche contenenti tali composti. | |
| PH18091A (en) | Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof | |
| PT64771B (fr) | Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-nitro-difenilicos. | |
| FR2527597B1 (fr) | Derives d'alcool b,g-dihydropolyprenylique et composition pharmaceutique contenant un compose polyprenylique | |
| FI822670A0 (fi) | Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling | |
| BE879472A (fr) | Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines | |
| FI790922A (fi) | 2,6-dialkoxibenzamider mellanprodukter farmaceutiska kompositioner och foerfarande foer behandling av psykotiska sjukdomar | |
| FI792319A (fi) | Guargum innehaollande farmaceutisk komposition | |
| IT7949064A0 (it) | Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina | |
| FI821051A0 (fi) | Pulverformig komposition innehaollande pesticider och laemplig foer behandling av husinredning | |
| FR2450814B1 (fr) | 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit | |
| BE854908A (fr) | Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant | |
| DK461579A (da) | Farmeceutisk komposition indeholdende en aryltrifluorethanol | |
| IT7951182A0 (it) | Antibiotico bn-183b,procedimento per produrlo e composizioni farmaceutiche che lo contengono | |
| BE867040A (fr) | Composition pharmaceutique contenant un nitro-imidazole | |
| PT68091A (fr) | Procede pour la preparation d'une composition herbicid contenant diuretane | |
| BE866422R (fr) | Nouvelles cephalosporines, leur preparation et compositions en contenant | |
| FR2547483B1 (fr) | Composition insecticide pour peinture et peinture la contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: FUJISAWA PHARMACEUTICAL CO. LTD Effective date: 19991008 |